Investment Committee and Board
Andrew Mackintosh (board member)
Andrew is a board member for ACF Investors.
Dr Mackintosh has had a distinguished career in industry and investment as a former CEO of FTSE 250 listed Oxford Instruments before later leading the creation of the Royal Society Enterprise Fund, a pioneering initiative in bringing together scientific expertise and early-stage investment. He has been a board member of the Intellectual Property Office, a trustee of the Design Council and chairman of Sphere Fluidics, a high-growth biotechnology tools company. He is currently a board member of Thames Ventures VCT 2 plc and chair of the UK Innovation and Science Seed Fund, a £100m government-backed venture capital fund supporting companies from the UK’s scientific research base.
He was the author in 2021 of the Mackintosh Report, commissioned by HM Treasury, which led to the creation of the new Government Office for Technology Transfer. He is a Fellow of the Royal Academy of Engineering and of the Institute of Physics and was awarded a CBE in the 2024 New Years Honours for services to Science and Technology, and to Enterprise Development.
The Investment Commitee is made up of 14 independent, experienced angel investors with either entrepreneurial or institutional investment backgrounds (or both). The Investment Committee is quorate at three members, but up to five could consider any single investment proposal.
The Board of ACF Investors includes Alliott Cole, Andrew Mackintosh, Marion Bernard and Vincent Neate.
